Literature DB >> 12475392

16K prolactin induces NF-kappaB activation in pulmonary fibroblasts.

Y Macotela1, C Mendoza, A M Corbacho, G Cosío, J P Eiserich, A Zentella, G Martínez de la Escalera, C Clapp.   

Abstract

The amino-terminal 16 kDa fragment of prolactin (16K PRL) promotes the expression of the inducible isoform of nitric oxide synthase (iNOS) accompanied by the production of nitric oxide (NO) by rat pulmonary fibroblasts. The present study was designed to elucidate whether the mechanism by which 16K PRL promotes iNOS expression involves the activation of nuclear factor-kappa B (NF-kappaB), a key transcription factor for iNOS induction. 16K PRL stimulated DNA-binding activity of NF-kappaB in pulmonary fibroblasts as demonstrated by gel shift assays. Likewise, fluorescence immunocytochemistry showed that 16K PRL promotes nuclear translocation of the p65 subunit of NF-kappaB. Finally, treatment with 16K PRL induced the degradation of the NF-kappaB inhibitor kappaB-beta (IkappaB-beta), and such degradation was prevented by blocking IkappaB-beta phosphorylation. Altogether, these results show that 16K PRL activates NF-kappaB nuclear translocation via the phosphorylation and degradation of IkappaB-beta. These findings are consistent with NF-kappaB being part of the signal transduction pathway activated by 16K PRL to induce iNOS expression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12475392     DOI: 10.1677/joe.0.175r013

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  5 in total

1.  Profiling serum biomarkers in patients with COPD: associations with clinical parameters.

Authors:  Victor Pinto-Plata; John Toso; Kwan Lee; Daniel Park; John Bilello; Hana Mullerova; Mary M De Souza; Rupert Vessey; Bartolome Celli
Journal:  Thorax       Date:  2007-03-13       Impact factor: 9.139

2.  Vasoinhibin is Generated and Promotes Inflammation in Mild Antigen-induced Arthritis.

Authors:  Georgina Ortiz; Maria G Ledesma-Colunga; Zhijian Wu; Jose F García-Rodrigo; Norma Adan; Oscar F Martinez-Diaz; Ericka A De Los Ríos; Fernando López-Barrera; Gonzalo Martínez de la Escalera; Carmen Clapp
Journal:  Endocrinology       Date:  2022-05-01       Impact factor: 5.051

Review 3.  The role of the prolactin/vasoinhibin axis in rheumatoid arthritis: an integrative overview.

Authors:  Carmen Clapp; Norma Adán; María G Ledesma-Colunga; Mariana Solís-Gutiérrez; Jakob Triebel; Gonzalo Martínez de la Escalera
Journal:  Cell Mol Life Sci       Date:  2016-03-29       Impact factor: 9.261

4.  Prolactin-induced neuroprotection against glutamate excitotoxicity is mediated by the reduction of [Ca2+]i overload and NF-κB activation.

Authors:  Nadia A Rivero-Segura; Edgar Flores-Soto; Selene García de la Cadena; Isabel Coronado-Mares; Juan C Gomez-Verjan; Diana G Ferreira; Erika Alejandra Cabrera-Reyes; Luísa V Lopes; Lourdes Massieu; Marco Cerbón
Journal:  PLoS One       Date:  2017-05-05       Impact factor: 3.240

5.  Human Prolactin Point Mutations and Their Projected Effect on Vasoinhibin Generation and Vasoinhibin-Related Diseases.

Authors:  Jakob Triebel; Christin J Friedrich; Andreas Leuchs; Gonzalo Martínez de la Escalera; Carmen Clapp; Thomas Bertsch
Journal:  Front Endocrinol (Lausanne)       Date:  2017-11-06       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.